Transcatheter Interventions Online 2023 - On Demand
Published: 17 March 2023
1h 8sPart 1 | Session 6 Session 1.3: Key Issues in TAVI
1h 2m 15sPart 1 | Session 7 Session 1.4: Live Cases and Discussions
1m 21sPart 1 | Session 8 Day Close
2m 52sPart 2 | Session 2 Day Welcome: Complex PCI
1h 3mPart 2 | Session 3 Session 2.1: Balloon Revolution
54m 58sPart 2 | Session 4 Session 2.2: Live Cases and Discussions
1h 2sPart 2 | Session 7 Session 2.3: Left Main & Bifurcations
1h 1m 6sPart 2 | Session 8 Session 2.4: Live Cases and Discussion
1m 38sPart 2 | Session 9 Day Close
2m 49sPart 3 | Session 1 Day Welcome: Debates & Controversies
59m 8sPart 3 | Session 2 Session 3.1: Keynote & Debate
1h 1m 40sPart 3 | Session 3 Session 3.2: Live Cases and Discussion
54m 54sPart 3 | Session 5 Session 3.3: Debates
3m 4sPart 3 | Session 6 Day Close
3m 4sPart 1 | Session 1 Day Welcome: Structural Heart Disease Nicolas M Van Mieghem, Azeem Latib, Kendra J Grubb, Lars Søndergaard, Didier Tchétché, Holger Thiele
58m 10sPart 1 | Session 2 Session 1.1: Atrioventricular Valve Replacement Beyond TEER? Azeem Latib, Kendra J Grubb, Lars Søndergaard, Didier Tchétché, Holger Thiele
Welcome to the on-demand sessions of Transcatheter Interventions Online 2023, broadcast live on 15-17 March 2023. If you missed the live broadcast, here you can access all sessions in full.
TIO 2023 brought together a leading international faculty to create a rich, interactive experience to support the global interventional cardiology community stay abreast of the latest developments in transcatheter treatment strategies. Combining expert opinion and discussion, presentations and live cases from centres of excellence from both sides of the Atlantic, TIO 2023 again delivered best-in-class learning, supporting the latest in diagnosis, treatment strategies and patient management.
The live version of Transcatheter Interventions Online 2023 was CME-accredited. This on-demand version is not.
A CME-accredited version of each session of TIO 2023 will soon be available on Radcliffe Medical Education.
Key Learning Objectives
- Compare the utility of repair and replacement valve technology in mitral regurgitation
- Individualise valve choice for aortic regurgitation based on valve durability and patient features
- Recall the utility and limitations of specialty balloons
- Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
- Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
- Identify suitable patients for interatrial shunting
- Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
- Interventional Cardiologists
- Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
- Interventional Cardiology Nurses
More from this programme
Day One: Structural Heart Disease
Day Two: Complex PCI
Day Three: Debates and Controversies
Section Head of Interventional Cardiology
Dr Mohamed Azeem Latib is a world-leading expert in Interventional Cardiology. Dr Latib is the Section Head and Director of Interventional Cardiology as well as the Director of Structural Heart Interventions at the Montefiore-Einstein Center for Heart and Vascular Care.
He is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3).
His focus is on complex coronary interventions as well as transcatheter aortic, mitral and tricuspid interventions. His main clinical interests include Complex Coronary Interventions, Structural Heart Disease and New Device Innovation. He has extensive clinical experience in TAVR and MitraClip, as well as expertise in novel and new devices to treat mitral and tricuspid valve disease minimally invasively without open-heart surgery.
Dr Latib is currently involved in the development of the NeoChord NeXuS Transcatheter Mitral Chordal…
Kendra J Grubb
Dr Kendra Grubb is the surgical director of the Emory Structural Heart and Valve Center. She is also an associate professor of surgery at Emory University School of Medicine.
Kendra is a champion for women's heart disease and is dedicated to improving the lives of all patients through innovation, collaboration and a patient-centred approach to the treatment of cardiovascular disease.
Her clinical interests include valve repair or replacement, coronary artery bypass graft surgery (CABG), transcatheter aortic valve replacement (TAVR) and hybrid coronary revascularization.
Dr Grubb research interests are innovative cardiac surgery technologies. She has led and participated in multiple clinical trials of innovative cardiac surgery technologies, including studies of transcatheter aortic valve replacement (TAVR), MitraClip percutaneous therapy and the GORE® conformable TAG® thoracic endoprosthesis for the primary treatment of…
Nicolas M Van Mieghem
Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.
Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors.
His current research focuses on cerebral embolic protection during TAVI and the search for improved…
Professor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark. Professor of Cardiology at University of Copenhagen, he published over 300 peer reviewed articles, and more than 15 textbook chapters. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions, as well as congenital and structural heart diseases. He led the first-in-human transcatheter mitral valve implantation (CardiAQ) in 2012 and he actively participated to several trials, including NOTION (transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and low surgical risk), and the REDUCE randomised trial (PFO vs anti-platelet therapy after cryptogenic stroke).
Didier Tchétché, (Clinique Pasteur, Toulouse, France) Graduated from the University of Paris V where Dr Tchétché obtained his post-graduate diploma of cardiovascular pathology in 2004. From 2004 to 2005, he completed a 12-month fellowship period in the Hemodynamic and Interventional Cardiology department of Clinique Pasteur in Toulouse and from 2005 to 2007 he was Head Assistant at the intensive care unit of Bichât Hospital in Paris.
In 2008, he joined the interventional cardiovascular group in Clinique Pasteur, Toulouse, and he is currently Head of the Structural programme with an experience of more than 5000 TAVI procedures. His main areas of interest are coronary interventions and valvular heart disease. He has been actively involved in many clinical trials involving new technologies and devices in the field of interventional cardiology.
Deputy Head of the Department at Heart Center Leipzig
Prof Philipp Lurz is Deputy Head of the Department at Heart Center Leipzig, Germany, a position he has held since 2018. Previously, Prof Lurz was a Clinical Research Fellow at Great Ormond Street Hospital for Children NHS Foundation Trust. He completed his education at the University of Leipzig, and is a member of the German Society of Cardiology. Philipp is widely published in leading international peer-reviewed journals.